RP Bio Inc. (314140) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for RP Bio Inc. (314140:KRX), powered by AI.

Current Price
₩5,560
P/E Ratio
10.3
Market Cap
48.2B
Sector
Healthcare
What is the RP Bio Inc. stock price forecast?

RP Bio Inc. is currently trading at ₩5,560. View real-time AI analysis on Alpha Lenz.

What is RP Bio Inc. insider trading activity?

View the latest insider trading data for RP Bio Inc. on Alpha Lenz.

What is RP Bio Inc.'s P/E ratio?

RP Bio Inc.'s P/E ratio is 10.3.

RP Bio Inc.

KRX · 314140
₩5,560+30(+0.54%)Market closedKRX regular session 09:00–15:30 KST
Ask about RP Bio Inc.'s future dividend policy...
Alpha Chat Insight

RP Bio Inc. trades at a P/E of 10.3 (undervalued) with modest ROE of 4.5%.

Ask for details

Company Overview

RP Bio Inc. is a biotechnology company dedicated to advancing scientific research and development in the healthcare and pharmaceutical industries. Its primary focus is on the discovery, development, and commercialization of innovative therapies aimed at addressing unmet medical needs. RP Bio Inc. engages in extensive research to develop new drug candidates, utilizing cutting-edge technologies and scientific insights. The company operates within the highly competitive biotech sector, which notably includes research institutions, pharmaceutical companies, and various healthcare organizations. RP Bio Inc. plays a vital role in the market by contributing to the pipeline of potential treatments and therapies, thereby impacting the overall landscape of medical solutions available to patients and healthcare providers. Through its commitment to innovation, RP Bio Inc. strives to make significant contributions to the lifesaving drugs and treatments that advance global healthcare.

CEO윤재훈
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
0

Company Statistics

FY 2025

Profile

₩48,184,967,160Market Cap
₩136,218,902,140Revenue
8.67MShares Out
0Employees

Margins

10.16%Gross
8.85%EBITDA
3.73%Operating
3.40%Pre-Tax
3.44%Net

Valuation

10.29P/E
0.45P/B
0.35EV/Sales
4.79EV/EBITDA
7.02P/FCF

Growth (CAGR)

-0.46%Rev 3Yr
6.82%Rev 5Yr
-19.21%Op Inc 3Yr
4.12%Op Inc 5Yr
2.76%Net Inc 3Yr
0.29%Net Inc 5Yr

Returns

2.97%ROA
4.47%ROE
3.46%ROIC

Financial Health

₩9,848,080,410Cash & Cash Equivalents
₩39,209,848,070Net Debt
45.76%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

RP Bio Inc. (ticker: 314140) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). Market cap is $48.2B.

The current price is ₩5,560 with a P/E ratio of 10.29x and P/B of 0.45x.

ROE is 4.47% and operating margin is 3.73%. Annual revenue is $136.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
RP Bio Inc. (314140) Stock Forecast 2026 ₩5,560 — Price, Financials & Analyst Targets | Alpha Lenz